To:
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`Pipeline Health Holdings LLC (syvia@mbvlaw.com)
`
`U.S. TRADEMARK APPLICATION NO. 85126414 - PIPELINE HEALTHCARERX - N/A
`
`3/3/2011 8:57:13 AM
`
`ECOM113@USPTO.GOV
`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
`
`(cid:160)(cid:160)(cid:160) CORRESPONDENT ADDRESS:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`*85126414*
`
`CLICK HERE TO RESPOND TO THIS LETTER:
`http://www.uspto.gov/teas/eTEASpageD.htm
`
`syvia@mbvlaw.com
`
`PRIORITY ACTION
`
`STRICT DEADLINE TO RESPOND TO THIS LETTER(cid:160)
`TO AVOID ABANDONMENT OF APPLICANT’S TRADEMARK APPLICATION, THE USPTO MUST RECEIVE APPLICANT’S
`COMPLETE RESPONSE TO THIS LETTER WITHIN 6 MONTHS OF THE ISSUE/MAILING DATE BELOW.
`
`(cid:160)I
`
`SSUE/MAILING DATE: 3/3/2011
`
`(cid:160)I
`
`SSUES APPLICANT MUST ADDRESS:(cid:160) On March 3, 2011, the trademark examining attorney and Syvia L. Magid discussed the issues
`below.(cid:160) Applicant must timely respond to these issues.(cid:160) See 15 U.S.C. §1062(b); 37 C.F.R. §2.62(a); TMEP §§708, 711.
`
`On February 11, 2011, applicant submitted a response in which it (1) amended its identification; (2) amended its mark; and (3) submitted an
`additional disclaimer.(cid:160) These amendments are acceptable and have been entered; therefore the requirements for an acceptable identification, a
`matching drawing and specimen and a complete disclaimer are now satisfied.(cid:160) However, applicant should note the new specimen requirement.
`
`(cid:160)S
`
`pecimen Unacceptable for International Class 45
`
`(cid:160)T
`
`he specimen is not acceptable for the services in International Class 45 because it does not show the applied-for mark used in connection with
`any of the services specified in the application.(cid:160) An application based on Trademark Act Section 1(a) must include a specimen showing the
`applied-for mark in use in commerce for each class of goods and/or services.(cid:160) Trademark Act Sections 1 and 45, 15 U.S.C. §§1051, 1127; 37
`
`C.F.R. §§2.34(a)(1)(iv), 2.56(a); TMEP §§904, 904.07(a).(cid:160)(cid:160)
`In this case, the specimen of record makes no reference to online social networking services whatsoever.(cid:160)(cid:160)
`
`Therefore, applicant must submit the following:
`
`(1)(cid:160) A substitute specimen showing the mark in use in commerce for each class of goods and/or services specified in the application; and
`
`(2)(cid:160) The following statement, verified with an affidavit or signed declaration under 37 C.F.R. §2.20:(cid:160) “ The substitute specimen was
`in use in commerce at least as early as the filing date of the application.” (cid:160) 37 C.F.R. §2.59(a); TMEP §904.05; see 37 C.F.R.
`
`(cid:160) (cid:160)(cid:160)(cid:160) APPLICATION SERIAL NO. 85126414
`(cid:160)(cid:160)(cid:160)(cid:160) MARK: PIPELINE HEALTHCARERX(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) (cid:160)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) APPLICANT:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) Pipeline Health Holdings LLC(cid:160)(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160) CORRESPONDENT’S REFERENCE/DOCKET NO :(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160)(cid:160)(cid:160)
`N/A(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) CORRESPONDENT E-MAIL ADDRESS:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`SYVIA L. MAGID(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`MBV LAW LLP(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`SAN FRANCISCO, CA 94111-1411(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`855 FRONT ST
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`

`

`§2.193(e)(1).(cid:160) If submitting a substitute specimen requires an amendment to the dates of use, applicant must also verify the amended
`dates.(cid:160) 37 C.F.R. §2.71(c); TMEP §904.05.
`
`(cid:160)E
`
`xamples of specimens for services are signs, photographs, brochures, website printouts or advertisements that show the mark used in the actual
`sale or advertising of the services.(cid:160) See TMEP §§1301.04 et seq.
`
`(cid:160)I
`
`f applicant cannot satisfy the above requirements, applicant may amend the application from a use in commerce basis under Section 1(a) to an
`intent to use basis under Section 1(b), for which no specimen is required.(cid:160) See TMEP §806.03(c).(cid:160) However, if applicant amends the basis to
`Section 1(b), registration will not be granted until applicant later amends the application back to use in commerce by filing an acceptable
`
`allegation of use with a proper specimen.(cid:160) See 15 U.S.C. §1051(c), (d); 37 C.F.R. §§2.76, 2.88; TMEP §1103.(cid:160)(cid:160)
`
`To amend to Section 1(b), applicant must submit the following statement, verified with an affidavit or signed declaration under 37 C.F.R. §2.20:(cid:160)
`“ Applicant has had a bona fide intention to use the mark in commerce on or in connection with the goods and/or services listed in the
`application as of the filing date of the application.” (cid:160) 37 C.F.R. §2.34(a)(2); TMEP §806.01(b); see 15 U.S.C. §1051(b); 37 C.F.R.
`§§2.35(b)(1), 2.193(e)(1).
`
`(cid:160)P
`
`ending receipt of a proper response, registration is refused because the specimen does not show the applied-for mark in use in commerce as a
`trademark and/or service mark for the identified goods and/or services.(cid:160) Trademark Act Sections 1 and 45, 15 U.S.C. §§1051, 1127; 37 C.F.R.
`§§2.34(a)(1)(iv), 2.56(a); TMEP §§904, 904.07(a).
`
`(cid:160)P
`
`artial Abandonment Advisory
`
`(cid:160)I
`
`f applicant does not respond to this Office action within the six-month period for response, then International Class 45 will be deleted from the
`application and the application will proceed forward for International Classes 35, 38, 41, 42 and 44 only.(cid:160) 37 C.F.R. §2.65(a).
`
`A prompt response to this Office Action will expedite prosecution.
`
`/Aisha Y. Salem/
`Aisha Y. Salem
`Trademark Examining Attorney
`Law Office 113
`Tel: (571) 272-8242
`Fax: (571) 273-9113
`Aisha.Salem@uspto.gov
`
`(cid:160)T
`
`O RESPOND TO THIS LETTER: (cid:160) Use the Trademark Electronic Application System (TEAS) response form at
`http://teasroa.uspto.gov/roa/.(cid:160) Please wait 48-72 hours from the issue/mailing date before using TEAS, to allow for necessary system updates of
`the application.(cid:160) For technical assistance with online forms, e-mail TEAS@uspto.gov.(cid:160) For(cid:160)questions about the Office action itself, please
`contact the assigned examining attorney.(cid:160)(cid:160) Do not respond to this Office action by e-mail;(cid:160)the USPTO does not accept e-mailed responses .
`
`(cid:160)W
`
`HO MUST SIGN THE RESPONSE:(cid:160) It must be personally signed by(cid:160)an individual applicant or(cid:160)someone with legal authority to bind an
`applicant (i.e., a corporate officer, a general partner, all joint applicants).(cid:160)(cid:160)If an applicant is represented by an attorney, the attorney must sign the
`response.
`
`(cid:160)P
`
`ERIODICALLY CHECK THE STATUS OF THE APPLICATION: (cid:160) To ensure that applicant does not miss crucial deadlines or official
`notices, check the status of the application every three to four months using Trademark Applications and Registrations Retrieval (TARR) at
`http://tarr.uspto.gov/. (cid:160) Please keep a copy of the complete TARR screen. (cid:160) If TARR shows no change for more than six months, call
`1-800-786-9199. (cid:160) For more information on checking status, see http://www.uspto.gov/trademarks/process/status/.
`
`(cid:160)T
`
`O UPDATE CORRESPONDENCE/E-MAIL ADDRESS:(cid:160) Use the TEAS form at http://www.uspto.gov/teas/eTEASpageE.htm.
`
`(cid:160)(cid:160)
`(cid:160)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`

`

`To:
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`Pipeline Health Holdings LLC (syvia@mbvlaw.com)
`
`U.S. TRADEMARK APPLICATION NO. 85126414 - PIPELINE HEALTHCARERX - N/A
`
`3/3/2011 8:57:16 AM
`
`ECOM113@USPTO.GOV
`
`IMPORTANT NOTICE REGARDING YOUR
`U.S. TRADEMARK APPLICATION
`
`USPTO OFFICE ACTION HAS ISSUED ON 3/3/2011 FOR
`SERIAL NO. 85126414
`
`lease follow the instructions below to continue the prosecution of your application:
`
`(cid:160)P
`
`TO READ OFFICE ACTION: Click on this link or go to http://portal.uspto.gov/external/portal/tow and enter the application serial
`number to access the Office action.
`
`(cid:160)P
`
`LEASE NOTE: The Office action may not be immediately available but will be viewable within 24 hours of this e-mail notification.
`
`(cid:160)R
`
`ESPONSE(cid:160)IS REQUIRED: You should carefully review the Office action to determine (1) how to respond; and (2) the applicable response
`time period. Your response deadline will be calculated from 3/3/2011 (or sooner if specified in the office action).
`
`(cid:160)D
`
`o NOT hit “Reply” to this e-mail notification, or otherwise attempt to e-mail your response, as the USPTO does NOT accept e-mailed
`responses.(cid:160) Instead, the USPTO recommends that you respond online using the Trademark Electronic Application System Response
`Form.
`
`(cid:160)H
`
`ELP: For technical assistance in accessing the Office action, please e-mail
`
`TDR@uspto.gov.(cid:160) Please contact the assigned examining attorney with questions about the Office action.(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) WARNING
`
`(cid:160)F
`
`ailure to file the required response by the applicable deadline will result in the ABANDONMENT of your
`application.
`
`(cid:160)
`(cid:160)(cid:160)
`(cid:160)(cid:160)(cid:160)
`